[Heart transplantation in infants--a new option].

Abstract

Nowadays orthotopic heart transplantation is world wide accepted as a therapeutic concept in endstage congestive heart failure. Concerning infants, there are still major objections against this kind of therapy and especially in our country exists only very limited experience. Since march 1988 we have performed an orthotopic heart transplantation in 10 pediatric patients: 5 infants (2-16 years of age) with congestive cardiomyopathy, 1 newborn with endocardial fibroelastosis, 3 newborns with hypoplastic left heart syndrome, and finally 1 infant at the age of 2 years with AV-canal and hypoplastic left ventricle. Until now 6 infants survived and are all at home and in good clinical condition. There have been no signs for chronic rejection or graft atherosclerosis up till now. As demonstrated in the example of the newborn, in whom we performed the first successfully orthotopic heart transplantation in Germany, the clinical course and quality of life are superior to those after other palliative procedures in complex cardiac malformations.

• Authors: H Netz, J Bauer, J Kreuder, R Moosdorf, F W Hehrlein
• Journal: Klinische Padiatrie (Klin Padiatr) 1991 Mar-Apr Vol. 203 Issue 2 Pg. 72-6 ISSN: 0300-8630 [Print] Germany
• Vernacular Title: Herztransplantation bei Kleinkindern--eine neue Option.
• PMID: 2033908 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Immunosuppressive Agents

Topics

• Adolescent
• Cardiomyopathy, Dilated (surgery)
• Child
• Child, Preschool
• Drug Therapy, Combination
• Endocardial Fibroelastosis (pathology, surgery)
• Heart Defects, Congenital (surgery)
• Heart Transplantation
• Humans
• Immunosuppressive Agents (administration & dosage)
• Infant